- CEO
- David Halabu
- Full Time Employees
- 6
- Sector
- Technology
- Industry
- Software - Services
- Address
- 500 Andrews Ave Fort Lauderdale FL United States of America 33301
- IPO Date
- Dec 17, 2020
- Business
- Z Squared Inc. engages in the design, development, and deployment of computing infrastructure and AI-enabled analytics platforms to support enterprise-scale data processing, power management, and strategic asset optimization. The company operates through Biotechnology and Technology-focused segments, pursuing pipelines in life sciences alongside advanced technology acquisitions to enhance operational capability. Headquartered in Wexford, Pennsylvania, and founded in 2017, Z Squared delivers a vertically integrated platform that integrates high-density compute, energy efficiency, real-time analytics, and hardware lifecycle management to enable scalable industrial and research applications across diverse sectors.
Main products and services: compute infrastructure platforms for AI and data processing; power management solutions optimized for grid conditions and interconnection constraints; real-time analytics dashboards and monitoring software; hardware lifecycle programs including procurement, deployment, maintenance, and end-of-life planning; technology asset acquisitions and integration services to augment existing IT and OT environments; advisory services on data center siting, energy efficiency, and grid interactivity; brand-specific offerings and solution packages within enterprise computing and digital infrastructure.
Latest major company changes: completes business combination with Coeptis Therapeutics Holdings Inc. and lists on the Nasdaq Global Market under ticker ZSQR; appoints executive leadership to advance AI infrastructure strategy, with a Co-Chief Executive Officer and a Chief Marketing Officer to steer brand and investor communications; focuses on pursuing AI infrastructure opportunities emphasizing power-advantaged sites, high-density compute, and disciplined deployment amid energy and cooling constraints; expands leadership and governance structures to support expanded operations and integration of biopharmaceutical and technology assets; discloses details of share ownership and post-merger capitalization, signaling a strategic shift toward a diversified platform combining biotech and tech-enabled services.
Industry and business segments: enterprise computing infrastructure; AI and data analytics platforms; energy-efficient data processing; hardware lifecycle and asset management; strategic technology asset acquisitions; biopharmaceutical infrastructure integration post-merger.
Target markets and customer types: mid-to-large corporate and institutional clients seeking scalable AI compute, data analytics, and energy-efficient data center solutions; life sciences and biopharma entities requiring integrated biotech and IT infrastructure; investors and stakeholders seeking exposure to a diversified technology and biotech platform.
Geographic operations: operations and market activity across the United States with headquarters in Pennsylvania, and a focus on scalable sites and infrastructure assets in multiple regions to support distributed computing and AI deployments.
Founding year and headquarters location: founded in 2017; headquarters in Wexford, Pennsylvania, USA.
Subsidiaries and parent relationships: merged with Coeptis Therapeutics Holdings Inc., creating a combined entity listed on Nasdaq under ZSQR; former Z Squared Opco stockholders retain a majority stake post-merger, while Coeptis stockholders receive a pro rata distribution of its subsidiary ownership, positioning the combined company with an integrated biotech-tech footprint.